Viive M Howell

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Liver Metastases

Top Venues

Journal of clinical medicine

Scientific reports

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda L Hudson, Angela Cho, Emily K Colvin, Sarah A Hayes, Helen R Wheeler, Viive M Howell
CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma. Cancers 16 (5) (2024)
Amanda L Hudson, Angela Cho, Emily K Colvin, Sarah A Hayes, Helen R Wheeler, Viive M Howell
CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma. Cancers 16 (5) (2024)
Christopher B Nahm, John Turchini, Sumit Sahni, Elizabeth Moon, Malinda Itchins, Jennifer Arena, Angela Chou, Emily K Colvin, Viive M Howell, Nick Pavlakis, Stephen Clarke, Jaswinder S Samra, Anthony J Gill, Anubhav Mittal
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer. Cancers 14 (15) (2022)
Emily K Colvin, Amanda L Hudson, Lyndsey L Anderson, Ramyashree Prasanna Kumar, Iain S McGregor, Viive M Howell, Jonathon C Arnold
An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma. Cancers 14 (15) (2022)
Katherine B Sahin, Esha T Shah, Genevieve P Ferguson, Christopher Molloy, Priyakshi Kalita-de Croft, Sarah A Hayes, Amanda Hudson, Emily Colvin, Hannah Kamitakahara, Rozelle Harvie, Csilla Hasovits, Tashbib Khan, Pascal H G Duijf, Viive M Howell, Yaowu He, Emma Bolderson, John D Hooper, Sunil R Lakhani, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer. Cancers 13 (18) (2021)
Sarah Maloney, Malinda Itchins, Jennifer Arena, Sumit Sahni, Viive M Howell, Sarah A Hayes, Anthony J Gill, Stephen J Clarke, Jaswinder Samra, Anubhav Mittal, Nick Pavlakis
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. Journal of clinical medicine 10 (12) (2021)
Archana Prashanth, Heather Donaghy, Shihani P Stoner, Amanda L Hudson, Helen R Wheeler, Connie I Diakos, Viive M Howell, Georges E Grau, Kelly J McKelvey
Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? Cancers 13 (5) (2021)
Emily K Colvin, Viive M Howell
Why the dual origins of high grade serous ovarian cancer matter. Nature communications 11 (1) (2020)
Razia Zakarya, Viive M Howell, Emily K Colvin
Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches. International journal of molecular sciences 21 (13) (2020)
Fatemeh Vafaee, Emily K Colvin, Samuel C Mok, Viive M Howell, Goli Samimi
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis. Scientific reports 7 (1) (2017)